| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.004 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |